
Morgan Stanley upgraded Citizens Financial Group (CFG) to Overweight from Equalweight, raising its price target to $71 from $53, citing the bank's strong profitability improvement narrative, current discount valuation, and anticipated catalysts such as its Private Bank buildout and lower capital requirements post-2026 stress tests. The firm projects CFG's Return on Tangible Common Equity (ROTCE) to increase from 11% in Q2 2025 to 15% by 2027, with the new price target implying a 33% upside. This positive outlook is echoed by other recent analyst price target increases from Truist and Citi, alongside CFG's recent appointment of a new CFO and a prime lending rate reduction.
Citizens Financial Group (CFG) has received a significant endorsement from Morgan Stanley, which upgraded the stock to Overweight and raised its price target to $71.00, implying a 33% upside from its current price of $53.38. The core of the thesis is a multi-year profitability improvement story, with Morgan Stanley projecting CFG's Return on Tangible Common Equity (ROTCE) to expand from 11% in Q2 2025 to 15% by 2027, closing the valuation gap with its peers. This growth is expected to be driven by several catalysts, including the buildout of its Private Bank, improving credit conditions, and anticipated lower capital requirements following the 2026 stress tests. The positive sentiment is shared by other analysts, with both Truist Securities and Citi recently raising their price targets. Fundamentally, the stock is described as slightly undervalued, trading at a 16.22x P/E ratio while offering a 3.15% dividend yield. Recent corporate developments, such as the appointment of a new CFO from Barclays and a reduction in its prime lending rate, further supplement the bank's operational and strategic positioning.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment